Jefferies Group LLC Accelerate Diagnostics, Inc Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.54 - $1.41 $8,195 - $21,398
15,176 New
15,176 $5,000
Q1 2019

May 15, 2019
SELL
$11.76 - $22.15 $124,597 - $234,679
-10,595 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$10.42 - $21.94 $110,399 - $232,454
10,595 New
10,595 $122,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email